TrueBeam STx offers more advanced treatment capabilities compared to Gamma Knife and CyberKnife technologies. Unlike Gamma Knife, which targets only intracranial tumors, TrueBeam STx can address various types of cancerous tumors. Although CyberKnife can also treat different tumors, it may not yield the same outcomes as TrueBeam STx, especially for larger foci.\n\nThe Bahçelievler Memorial Cancer Center has received accreditation from esteemed organizations such as the Organization of European Ca...